Research on the Operating Efficiency of Chinese Listed Pharmaceutical Companies Based on Two-Stage Network DEA and Malmquist | Zendy

TsungXian Lin | Zendy; Zhong-huan Wu | Zendy; Xiao-xia Ji | Zendy; Jia-jia Yang | Zendy

Open Access

Research on the Operating Efficiency of Chinese Listed Pharmaceutical Companies Based on Two-Stage Network DEA and Malmquist

Author(s) -

TsungXian Lin,

Zhong-huan Wu,

Xiao-xia Ji,

Jia-jia Yang

Publication year - 2021

Publication title -

mathematical problems in engineering

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.262

H-Index - 62

eISSN - 1026-7077

pISSN - 1024-123X

DOI - 10.1155/2021/1475781

Subject(s) - diseconomies of scale , malmquist index , subsidy , index (typography) , productivity , business , scale (ratio) , total factor productivity , government (linguistics) , industrial organization , china , economics , economies of scale , marketing , economic growth , computer science , market economy , political science , physics , quantum mechanics , linguistics , philosophy , world wide web , law

The development of pharmaceutical companies, which is an important part of the national economy and industry, is closely related to people’s livelihood issues. With the era of big data, this paper uses the two-stage DEA and Malmquist method to evaluate the efficiency of listed Chinese pharmaceutical companies. From a static and dynamic perspective, it analyses the total factor productivity index, pure efficiency change index, scale efficiency index, and so on. The results show that government subsidies have not had a positive impact on most Chinese pharmaceutical companies, and for films, diseconomies of scale caused by rapid expansion should be avoided.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research